切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2015, Vol. 01 ›› Issue (01) : 42 -47. doi: 10.3877/cma.j.jssn.2096-1537.2015.01.011

所属专题: 重症医学 文献

专家论坛

急性肾损伤:病理生理与治疗
刘海涛1, 于凯江1,*,*   
  1. 1. 150081 哈尔滨,哈尔滨医科大学
  • 收稿日期:2015-07-08 出版日期:2015-11-28
  • 通信作者: 于凯江
  • 基金资助:
    国家自然科学基金(81571871)

Acute kidney injury: pathophysiology and treatment

Haitao Liu1, Kaijiang Yu1   

  1. 1. Intensive Care Unit, Third Affiliated Hospital of Harbin Medical University, Harbin 150001, China
  • Received:2015-07-08 Published:2015-11-28
  • Corresponding author: Kaijiang Yu
  • About author:
    Corresponding author: Yu Kaijiang, Email: drkaijiang@163.com
引用本文:

刘海涛, 于凯江. 急性肾损伤:病理生理与治疗[J]. 中华重症医学电子杂志, 2015, 01(01): 42-47.

Haitao Liu, Kaijiang Yu. Acute kidney injury: pathophysiology and treatment[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2015, 01(01): 42-47.

急性肾损伤(AKI)是一种常见的临床综合征,主要表现为肾功能快速下降及代谢废物的蓄积,其诊断有赖于血清肌酐的升高和尿量减少。目前尚无治疗AKI的特效药物,严重时需进行肾脏替代治疗,因此早期发现和早期防治成为改善患者预后的关键。为加深对AKI的理解,提高AKI的诊疗水平,本文着重介绍AKI的诊断、病理生理及治疗的相关研究进展。

Acute kidney injury (AKI) is a common clinical syndrome and mainly manifested by the rapid decline of renal function and the accumulation of metabolic waste. The diagnosis of AKI depends on the increase of serum creatinine and/or the decrease of urinary output. Early detection, prevention, and treatment become the key points to improve the prognosis of AKI patients because specific therapies to treat of AKI are still unavailable currently. In order to deepen the understanding of AKI and improve the level of diagnosis and treatment of AKI, this paper focuses on the diagnosis, pathophysiology, and treatment of AKI.

表1 KDIGO的AKI分级诊断标准[4]
图1 AKI的分级管理[4]
[1]
Yang L, Xing GL, Wang L, et al. Acute kidney injury in China: a cross-sectional survey[J]. Lancet, 2015, 386(10002):1465–1471.
[2]
Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group[J]. Crit Care, 2004, 8(4):R204–R212.
[3]
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury[J]. Crit Care, 2007, 11(2):R31.
[4]
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGo clinical practice guideline for acute kidney injury[J]. Kidney Int, 2012, 2(Suppl):1–138.
[5]
Rachoin JS, Daher R, Moussallem C, et al. The fallacy of the BUN: creatinine ratio in critically ill patients[J]. Nephrol Dial Transplant, 2012, 27(6):2248–2254.
[6]
Prowle JR, Molan MP, Hornsey E, et al. Measurement of renal blood flow by phase-contrast magnetic resonance imaging during septic acute kidney injury: a pilot investigation[J]. Crit Care Med, 2012, 40(6):1768–1776.
[7]
Lerolle N, Nochy D, Guérot E, et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration[J]. Intensive Care Med, 2010, 36(3):471–478.
[8]
Fenhammar J, Rundgren M, Forestier J, et al. Toll-like receptor 4 inhibitor TAK-242 attenuates acute kidney injury in endotoxemic sheep[J]. Anesthesiology, 2011, 114(5):1130–1137.
[9]
Bellomo R, Wan L, Langenberg C, et al. Septic acute kidney injury: new concepts[J]. Nephron Exp Nephrol, 2008, 109(4):e95–e100.
[10]
Dindyal S, Kyriakides C. Ultrasound microbubble contrast and current clinical applications[J]. Recent Pat Cardiovasc Drug Discov, 2011, 6(1):27–41.
[11]
Xu HX. Contrast-enhanced ultrasound: the evolving applications[J]. World J Radiol, 2009, 1(1):15–24.
[12]
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock[J]. N Engl J Med, 2001, 345(19):1368–1377.
[13]
Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure[J]. Crit Care Med, 2004, 32(8):1669–1677.
[14]
Bagshaw SM, Delaney A. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis[J]. Crit Care Resusc, 2007, 9(1):60–68.
[15]
Wang Y, Cui Z, Fan M. Retrospective analysis on Chinese patients diagnosed with acute renal failure hospitalized during the last decade (1994-2003)[J]. Am J Nephrol, 2005, 25(5):514–519.
[16]
Wu VC, Ko WJ, Chang HW, et al. Early renal replacement therapy in patients with postoperative acute liver failure associated with acute renal failure: effect on postoperative outcomes[J]. J Am Coll Surg, 2007, 205(2):266–276.
[17]
Jacka MJ, Ivancinova X, Gibney RT. Continuous renal replacement therapy improves renal recovery from acute renal failure[J]. Can J Anaesth, 2005, 52(3):327–332.
[18]
Rabindranath K, Adams J, Macleod AM, et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults[J]. Cochrane Database Syst Rev, 2007, (3):CD003773.
[19]
De Smedt DM, Elseviers MM, Lins RL, et al. Economic evaluation of different treatment modalities in acute kidney injury[J]. Nephrol Dial Transplant, 2012, 27(11) :4095–4101.
[20]
Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial[J]. Lancet, 2000, 356(9223) :26–30.
[21]
Saudan P, Niederberger M, De Seigneux S, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure[J]. Kidney Int, 2006, 70(7) :1312–1317.
[22]
Network VNaRFT, Palevsky PM, Zhang JH, et al. Intensity of renal support in critically ill patients with acute kidney injury[J]. N Engl J Med, 2008, 359(1) :7–20.
[23]
Investigators RRTS, Bellomo R, Cass A, et al. Intensity of continuous renal-replacement therapy in critically ill patients[J]. N Engl J Med, 2009, 361(17) :1627–1638.
[24]
Joannes-Boyau O, Honoré PM, Perez P, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial[J]. Intensive Care Med. 2013, 39(9):1535–1546.
[1] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[2] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[3] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[4] 王宏宇. 固定与活动平台假体在全膝关节置换术中的应用价值[J]. 中华关节外科杂志(电子版), 2023, 17(06): 871-876.
[5] 李善武, 叶永杰, 王兵, 王子呓, 银毅, 孙官军, 张大刚. 胫骨高位截骨与单髁置换的早期疗效比较[J]. 中华关节外科杂志(电子版), 2023, 17(06): 882-888.
[6] 张伟. 牙及牙槽外科:舒适治疗的先锋[J]. 中华口腔医学研究杂志(电子版), 2023, 17(06): 386-388.
[7] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[8] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[9] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[10] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[11] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[12] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[13] 易成, 韦伟, 赵宇亮. 急性肾脏病的概念沿革[J]. 中华临床医师杂志(电子版), 2023, 17(08): 906-910.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要